Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: June 28, 2017
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms Usa Inc | ACETAZOLAMIDE | acetazolamide | CAPSULE, EXTENDED RELEASE;ORAL | 040904 | ANDA | KAISER FOUNDATION HOSPITALS | 0179-0050-70 | 30 CAPSULE, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0179-0050-70) | |||||||||||||||||||||
Zydus Pharms Usa Inc | ACETAZOLAMIDE | acetazolamide | CAPSULE, EXTENDED RELEASE;ORAL | 040904 | ANDA | American Health Packaging | 68084-401-21 | 30 BLISTER PACK in 1 CARTON (68084-401-21) > 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (68084-401-11) | |||||||||||||||||||||
Zydus Pharms Usa Inc | ACETAZOLAMIDE | acetazolamide | CAPSULE, EXTENDED RELEASE;ORAL | 040904 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-261-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-261-01) | |||||||||||||||||||||
Zydus Pharms Usa Inc | ACETAZOLAMIDE | acetazolamide | CAPSULE, EXTENDED RELEASE;ORAL | 040904 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-261-10 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-261-10) | |||||||||||||||||||||
Heritage Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 205530 | ANDA | Heritage Pharmaceuticals Inc. | 23155-287-01 | 100 TABLET in 1 BOTTLE (23155-287-01) | |||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
Join the 21,741 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
